Versant Voyageurs I Parallel, L.P.'s Net Worth
$37.8 Million
Who is Versant Voyageurs I Parallel, L.P.?
Versant Voyageurs I Parallel, L.P. has an estimated net worth of $37.8 Million. This is based on reported shares across multiple companies, which include CHINOOK THERAPEUTICS, INC., and Black Diamond Therapeutics, Inc..
SEC CIK
Versant Voyageurs I Parallel, L.P.'s CIK is 0001745961
Past Insider Trading and Trends
2020 was Versant Voyageurs I Parallel, L.P.'s most active year for acquiring shares with 48 total transactions. Versant Voyageurs I Parallel, L.P.'s most active month to acquire stocks was the month of January. 2020 was Versant Voyageurs I Parallel, L.P.'s most active year for disposing of shares, totalling 127 transactions. Versant Voyageurs I Parallel, L.P.'s most active month to dispose stocks was the month of October. 2020 saw Versant Voyageurs I Parallel, L.P. paying a total of $16,999,984.00 for 10,678,287 shares, this is the most they've acquired in one year. In 2022 Versant Voyageurs I Parallel, L.P. cashed out on 1,735,873 shares for a total of $16,000,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Black Diamond Therapeutics, Inc. (BDTX) Snapshot price: $3.865
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.47% | -20.78K |
—
|
—
| 822.14K |
Scheduled
|
Dec 14
| ||
Form 4
| -8.33% | -435.57K |
$33.15 | -$344,512.74 | 4.79M |
Scheduled
|
Nov 27 - Nov 30
| ||
Form 4
| -9.96% | -761.91K |
—
|
—
| 6.89M |
Nov 23
| |||
Form 4
| -2.20% | -130.02K |
$33.01 | -$4,291,861.17 | 5.79M |
Scheduled
|
Nov 19
| ||
Form 4
| -0.08% | -4.73K |
$33.05 | -$156,349.14 | 5.92M |
Scheduled
|
Nov 17 - Nov 18
| ||
Form 4
| -0.08% | -4.70K |
$33.74 | -$158,586.75 | 5.92M |
Scheduled
|
Nov 13 - Nov 16
| ||
Form 4
| -11.03% | -965.60K |
$34.15 | -$532,642.00 | 7.79M |
Scheduled
|
Nov 11 - Nov 12
| ||
Form 4
| -0.59% | -39.58K |
$34.11 | -$1,350,353.80 | 6.63M |
Scheduled
|
Nov 10 - Nov 11
| ||
Form 4
| -0.14% | -9.40K |
$33.08 | -$310,948.63 | 6.67M |
Scheduled
|
Nov 6 - Nov 9
| ||
Form 4
| -0.17% | -11.35K |
$33.14 | -$376,126.56 | 6.68M |
Scheduled
|
Nov 4 - Nov 5
| ||
Form 4
| -0.13% | -8.90K |
$33.28 | -$296,293.17 | 6.69M |
Scheduled
|
Oct 26 - Oct 27
| ||
Form 4
| -0.23% | -15.75K |
$33.44 | -$526,528.85 | 6.7M |
Scheduled
|
Oct 15 - Oct 19
| ||
Form 4
| -0.26% | -17.24K |
$33.30 | -$574,015.39 | 6.72M |
Scheduled
|
Oct 13 - Oct 14
| ||
Form 4
| -0.33% | -22.63K |
$33.50 | -$757,923.76 | 6.74M |
Scheduled
|
Oct 8 - Oct 12
| ||
Form 4
| -3.64% | -335.53K |
$33.44 | -$1,535,732.24 | 8.88M |
Scheduled
|
Oct 6 - Oct 7
| ||
Form 4
| -7.33% | -729.22K |
—
|
—
| 9.21M |
Scheduled
|
Sep 17
| ||
Form 4
| -4.62% | -300.00K |
—
|
—
| 6.2M |
Aug 18
| |||
Form 4
| -4.41% | -300.00K |
—
|
—
| 6.5M |
Scheduled
|
Aug 12
| ||
Form 4
| -0.17% | -13.79K |
$33.06 | -$455,989.33 | 7.92M |
Scheduled
|
Aug 10 - Aug 11
| ||
Form 4
| -8.08% | -329.22K |
—
|
—
| 3.75M |
Scheduled
|
Jul 27
| ||
Form 4
| +133.97% | 10.55M |
$19.00 | $9,474,426.00 | 18.43M |
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHINOOK THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.60% | -709.95K |
—
|
—
| 2.91M |
Scheduled
|
Apr 4
| ||
Form 4
| -14.21% | -1.00M |
$16.00 | -$16,000,200.00 | 6.04M |
Scheduled
|
Jan 3
| ||
Form 4
| -10.78% | -850.00K |
$14.00 | -$11,900,000.00 | 7.04M |
Aug 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||